Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Dexlansoprazole
Therapeutic Area : Gastroenterology
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Devonian’s Subsidiary Launches Generic Dexlansoprazole (Dexilant®) in Canada
Details : Dexilant-Generic (dexlansoprazole) is a proton pump inhibitor for healing erosive esophagitis and treating heartburn associated with non-erosive GERD.
Brand Name : Dexilant-Generic
Molecule Type : Small molecule
Upfront Cash : Not Applicable
February 27, 2024
Lead Product(s) : Dexlansoprazole
Therapeutic Area : Gastroenterology
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?